Innovating QA: Zhenis Ismagambetov’s Recipe For Success
A senior QA professional who innovates exclusive techniques that measure precision, efficiency, and success as part of today’s most ambitious endeavors. Quality Assurance (QA) is becoming an increasingly potent force in corporate revenue in the year 2024, as highlighted through scores of reports and surveys. Direct evidence comes from Medium’s annual survey on data quality, where a whopping 31% of revenue is affected by data quality rough edges.
This underlines the critical value of correct QA practices regarding data integrity, sound decision-making and operational efficiency. Quality Assurance is not merely about compliance; it is a strategic lever for revenue growth in different industries for the year 2024.
Therefore, by strategically putting QA processes on the front burner, organizations improve the possibility of increasing product quality, improving customer experience, and, ultimately, profit.
Zhenis Ismagambetov, a Senior QA Engineer at Publicis Sapient has an international perspective. This has contributed significantly to improving QA processes for large-scale projects that can impact the global environment. His writing experience on the Biomedical Research Informatics Computing System (BRICS) has given him an important operational view on how to use QA as a driver of innovation and efficiency.
His experiences across several industries have also given him a rather unique flavor of viewing how QA methodologies might be tweaked to get the best bang for the buck in measurable terms. Zhenis reveals his opinion on how QA is evolving, changing business fortunes, and what could trend and reshape the industry in the years 2024 and 2025.
And by BRICS comes the increasingly vital biomedical research informatics computing system, the brainchild of NIH and of DoD, which advances the study capability for trials and big health studies. It provides more features in collecting and storing data in an authenticated and regulatory-compliant environment at the same time enabling its application by the communities on their own and fostering international collaboration.
After being a Senior QA Engineer, BRICS has been enhanced in reliability and capacity as well. He automated the test scripts, resulting in a 40% reduced time in manual testing. Such improvement was not only in the efficiency of testing but also in the rapid outflow of the updated versions of the platform which resulted in an increase of 30% in update frequency.
He was asked to tell about the inspiration that drove the team in the making of the BRICS platform and how exactly the role of his skill set in quality assurance led to the success of the same.
In response, he said that the BRICS platform was the result of a compelling need to solve the chronic inefficiencies in biomedical research, and specifically, the difficulties with the management and analysis of large datasets by different teams. His quality assurance background enabled him to focus on a smooth and user-friendly experience for researchers.
He introduced sophisticated automation tools like Selenium WebDriver and cucumber scripting to make tests more accurate when testing the platform under complicated conditions. In addition, he worked closely with NIH stakeholders to influence feature development with cross-functional teams, ensuring the continuous evolution of the platform. It could satisfy changing researcher requirements, ultimately making it a very powerful tool for advancing science.
The question about the trends surrounding quality assurance and healthcare technologies that will have an impact in the future was raised.
He noted a major trend in the increasing use of AI and machine learning for quality assurance activities. Such technological advances afford the possibility of not only an early prediction and identification of potential issues but also the improvement of the testing workflow. These enhancements will positively affect solution delivery in healthcare, where accuracy and reliability are of extreme importance, making it faster and more accurate.
Additionally, he mentioned that quality assurance is increasingly integrated within the first phases of the development lifecycle, which is a more progressive approach to ensure that quality is built into the product rather than being corrected later on.
He also foresaw a greater emphasis on interoperability within healthcare technology, which simply means that different platforms and systems support industry research and patient care seamlessly across their divergent environments.